The collaboration sees Smith & Nephew working with REMEDI in speeding up the process of producing viable new orthopaedic therapies for dealing with osteoarthritis and cartilage repair.
 

"We are delighted to be working with the team at REMEDI, who are widely recognised and respected as world leaders in this field."

The aim of the Smith & Nephew collaboration with REMEDI is to develop a new generation of orthopaedic therapies that will help people to remain active and pain free for much longer by harnessing the healing power of adult stem cells to promote the growth of new cartilage or bone."

Peter Arnold, Group Director of Technology, Smith & Nephew